title: Challenges in Using MCDA for Reimbursement Decisions on New Medicines?
authors.affiliation: Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: Walker
mesh_terms: D026683:Advisory Committees; D003299:Cooperative Behavior; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D016527:Drug Costs; D017408:Guidelines as Topic; D015276:Health Care Rationing / Q000191:economics* / Q000592:standards; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics* / Q000592:standards; D033183:Interdisciplinary Communication; D009965:Orphan Drug Production / Q000191:economics; D019057:Quality-Adjusted Life Years; D012606:Scotland; D013222:State Medicine / Q000191:economics* / Q000592:standards